Danny Gauvreau
Research Subjects
Danny Gauvreau has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
Ian W. Davies
Merck Frosst, Centre for Therapeutic Research, Department of Process Research, 16711 TransCanada Highway, Kirkland, Québec, Canada, H9H 3L1
2 shared publicationsPaul D. O’sHea
Merck Frosst, Centre for Therapeutic Research, Department of Process Research, 16711 TransCanada Highway, Kirkland, Québec, Canada, H9H 3L1
2 shared publicationsBing Yu
Merck Frosst, Centre for Therapeutic Research, Department of Process Research, 16711 TransCanada Highway, Kirkland, Québec, Canada, H9H 3L1
1 shared publicationDaniel J. McKay
Merck Frosst, Centre for Therapeutic Research, Department of Process Research, 16711 TransCanada Highway, Kirkland, Québec, Canada, H9H 3L1
1 shared publicationGreg Hughes
Department of Process Research, Merck Frosst Centre for Therapeutic Research, 16711 Trans Canada Hwy, Kirkland, Québec, Canada H9H 3L1
1 shared publicationGreg J. Hughes
Merck Frosst, Centre for Therapeutic Research, Department of Process Research, 16711 TransCanada Highway, Kirkland, Québec, Canada, H9H 3L1
1 shared publication
Latest Publications
- 25 November 2010
- Published by Georg Thieme Verlag KG in Synlett
- Vol. 2010 (20) , 3086-3088
Convergent Approach to Nonsymmetrical 2,5-Diester Pyrroles
A convergent approach towards nonsymmetrical 2,5-diester pyrroles is described. The building blocks can be easily assembled in less than four steps allowing for facile construction of diversity. The synthesis uses a rhodium-catalyzed NH insertion, followed by a one-pot deprotection-condensation to yield the desired pyrroles.
- 25 November 2010
- Published by Georg Thieme Verlag KG in Synlett
- Vol. 2010 (20) , 3086-3088
Convergent Approach to Nonsymmetrical 2,5-Diester Pyrroles
A convergent approach towards nonsymmetrical 2,5-diester pyrroles is described. The building blocks can be easily assembled in less than four steps allowing for facile construction of diversity. The synthesis uses a rhodium-catalyzed NH insertion, followed by a one-pot deprotection-condensation to yield the desired pyrroles.
- 14 October 2010
- Published by American Chemical Society (ACS) in Organic Letters
- Vol. 12 (22) , 5146-5149
Practical Synthesis of a Renin Inhibitor via a Diastereoselective Dieckmann Cyclization
A scalable synthesis of a potent renin inhibitor (1) is described. The absolute stereochemistry is set via an unprecedented diastereoselective Dieckmann cyclization directed by a remote chiral protecting group. This transformation enables preparation of chiral 1,3-[3.3.1]-diazabicyclononenes by desymmetrization of alkyl-esters, with selectivities ranging from 4 to 17:1.
- 14 October 2010
- Published by American Chemical Society (ACS) in Organic Letters
- Vol. 12 (22) , 5146-5149
Practical Synthesis of a Renin Inhibitor via a Diastereoselective Dieckmann Cyclization
A scalable synthesis of a potent renin inhibitor (1) is described. The absolute stereochemistry is set via an unprecedented diastereoselective Dieckmann cyclization directed by a remote chiral protecting group. This transformation enables preparation of chiral 1,3-[3.3.1]-diazabicyclononenes by desymmetrization of alkyl-esters, with selectivities ranging from 4 to 17:1.
- 14 May 2010
- Published by American Chemical Society (ACS) in The Journal of Organic Chemistry
- Vol. 75 (12) , 4078-4085
Scalable Synthesis of a Prostaglandin EP4 Receptor Antagonist
The evolution of scalable, economically viable synthetic approaches to the potent and selective prostaglandin EP4 antagonist 1 is presented. The chromatography-free synthesis of multikilogram quantities of 1 using a seven-step sequence (six in the longest linear sequence) is described. This approach has been further modified in an effort to identify a long-term manufacturing route. Our final synthesis involves no step requiring cryogenic (<−25 °C) conditions; comprises a total of four steps, only three of which are in the longest linear synthesis; and features the use of two consecutive iron-catalyzed Friedel−Crafts substitutions.
- 14 May 2010
- Published by American Chemical Society (ACS) in The Journal of Organic Chemistry
- Vol. 75 (12) , 4078-4085
Scalable Synthesis of a Prostaglandin EP4 Receptor Antagonist
The evolution of scalable, economically viable synthetic approaches to the potent and selective prostaglandin EP4 antagonist 1 is presented. The chromatography-free synthesis of multikilogram quantities of 1 using a seven-step sequence (six in the longest linear sequence) is described. This approach has been further modified in an effort to identify a long-term manufacturing route. Our final synthesis involves no step requiring cryogenic (<−25 °C) conditions; comprises a total of four steps, only three of which are in the longest linear synthesis; and features the use of two consecutive iron-catalyzed Friedel−Crafts substitutions.